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Abstract.  The platelet plasma membrane is lined by a 
membrane skeleton that appears to contain short actin 
filaments cross-linked by actin-binding protein.  Actin- 
binding protein is in turn associated with specific 
plasma membrane glycoproteins. The aim of this study 
was to determine whether the membrane skeleton 
regulates properties of the plasma membrane.  Platelets 
were incubated with agents that disrupted the associa- 
tion of the membrane skeleton with membrane glyco- 
proteins.  The consequences of this change on plasma 
membrane properties were examined.  The agents that 
were used were ionophore A23187 and dibucaine. 
Both agents activated calpain (the Ca2+-dependent  pro- 
tease),  resulting  in the hydrolysis of actin-binding  pro- 
tein and decreased association of actin with membrane 
glycoproteins. Disruption of actin-membrane interac- 
tions was accompanied by the shedding of proco- 
agulant-rich  microvesicles from the plasma membrane. 
The shedding of microvesicles correlated with the hy- 
drolysis of actin-binding protein and the disruption of 
actin-membrane  interactions.  When the calpain- 
induced disruption of actin-membrane  interactions was 
inhibited,  the shedding of microvesicles was inhibited. 
These data are consistent with the hypothesis that as- 
sociation of the membrane skeleton with the plasma 
membrane maintains  the integrity of the plasma mem- 
brane, preventing the shedding of procoagulant-rich 
microvesicles from the membrane of unstimulated 
platelets.  They raise the possibility that the 
procoagulant-rich microvesicles that are released under 
a variety of physiological and pathological conditions 
may result from the dissociation of the platelet mem- 
brane skeleton from its membrane attachment  sites. 
p 
LATELETS are rich in cytoskeletal proteins that regu- 
late the contractile  responses of these ceils. For exam- 
ple, granule contents are secreted as the granules  are 
centralized  by a ring of contracting  actin filaments and as- 
sociated myosin,  and fibrin clots are retracted when the in- 
teraction of myosin with actin filaments generates  sufficient 
tension to retract the filopodia to which fibrin is bound (see 
Fox,  1987; Nachmias and Yoshida,  1988, for reviews). 
The role of the cytoskeleton in the unstimulated platelet is 
less well understood. We have considered whether the cy- 
toskeleton might play a role in regulating  properties of the 
plasma membrane.  Like the plasma membrane of other cells, 
the platelet plasma membrane consists  primarily of a lipid 
bilayer with inserted proteins.  It is not clear what stabilizes 
the membrane, preventing  it from fragmenting,  or what de- 
termines its contours, maintains the phospholipid asymmetry, 
or directs the lateral distribution or function of glycoproteins 
in the membrane. It is often suggested that submembranous 
actin filaments are responsible for regulating these properties 
of membranes.  Although  filaments in platelets,  as in other 
cells, run beneath the plasma membrane, and although both 
lateral  associations and end-on associations of the filaments 
with the membrane have been described (Nachmias,  1983; 
Karlsson et al.,  1984; Boyles et al.,  1985; Escolar et al., 
1986;  Hartwig and Shevlin,  1986;  Nakata and Hirokawa, 
1987), it is hard to envisage how such filaments could impart 
the requisite flexibility to the membrane and allow the rapid 
changes in cell shape that can occur in response to stimula- 
tion.  It seems that a separate structure that  coats the lipid 
bilayer would be better suited for regulating these properties 
of the membrane and would allow their modulation by mech- 
anisms other than those that regulate the contractile activities 
of the cytoplasmic actin filaments. 
In fact, the only cell type in which these properties of the 
plasma membrane have been clearly shown to be regulated 
by the cytoskeleton is the human red blood cell. This cell 
does not contain cytoplasmic actin  filaments,  but rather a 
membrane skeleton composed of short actin filaments cross- 
linked  by spectrin  that  is closely adherent  to the plasma 
membrane  (for  reviews,  see  Bennett,  1985;  Marchesi, 
1985). It seems likely that other cells may contain a mem- 
brane skeleton in addition to the networks of actin filaments 
that fill their cytoplasm (Ben-Ze'ev et al., 1979; Apgar et al., 
1985). 
In recent years, we have provided evidence that platelets 
do indeed contain such a  structure (Fox,  1985a;  Fox and 
Boyles, 1988; Fox et al., 1988). Most of the actin filaments 
in platelets  exist in a three-dimensional  network that can be 
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forces from Triton X-100-1ysed platelets, and depolymerized 
when Ca  2+ is present in the lysis buffer (presumably as a re- 
sult of the action of the Ca2+-dependent protein, gelsolin). 
These filaments are not associated with any membrane gly- 
coprotein that we can detect in unstimulated platelets (Fox, 
1985a), but become associated with myosin (Fox and Phil- 
lips, 1982;  Carroll et al., 1982) and the glycoprotein (GP) ~ 
Ilb-Ma complex (Phillips et al., 1980) after platelet activa- 
tion. Presumably, these filaments are the ones that are in- 
volved in the contractile responses of  cells. However, a small 
amount of the actin filaments in Triton lysates has very dif- 
ferent properties. In contrast to the filaments involved in con- 
tractile functions, these filaments remain in the low-speed 
supernatant of platelets lysed with the conventional Triton 
X-100 lysis buffers; they can be sedimented only under high g 
forces (Fox, 1985a). They are resistant to the action of  gelso- 
lin (Fox, 1985a; Fox et al., 1988) and are selectively asso- 
ciated with specific membrane glycoproteins (Fox, 1985b). 
The filaments were identified  as such because they bind phal- 
loidin, but they are too short to be visualized by thin-section 
microscopy (Fox et al.,  1988).  They were shown to be a 
component of a structure that has an amorphous appearance 
and exists as a continuous layer that apparently follows the 
contours of the plasma membrane (Fox et al.,  1988).  We 
suggested that this structure represents a membrane skeleton 
similar to the one that coats the lipid bilayer of the red blood 
cell plasma membrane. Although this structure is probably 
associated with the cytoplasmic actin filaments in intact plate- 
lets (Fox et al.,  1988),  it is readily dissociated from these 
filaments in Triton X-100 lysates. 
Our aim in the present study was to determine whether the 
membrane skeleton regulates properties of the plasma mem- 
brane. The approach that we used to address this question 
was to incubate platelets with agents that dissociate the mem- 
brane skeleton from the plasma membrane and to determine 
the consequences of this dissociation. Disruption of the ac- 
tin-membrane interactions was accompanied by shedding of 
procoagulant-rich  microvesicles  from  the  plasma  mem- 
brane. These results suggest that the membrane skeleton is 
important in maintaining the integrity of the membrane in 
the unstimulated platelet. They raise the possibility that the 
procoagulant-rich microvesicles that are shed from platelets 
aggregating in response to physiological agonists may result 
from  activation-induced  modification  of  the  membrane 
skeleton. 
Chemical Co., St. Louis, MO) or 0.5 mM dibucaine-HCl (Sigma Chemical 
Co.).  Ionopbore A23187  was  added  in a  final  concentration of 0.2% 
(vol/voi) DMSO (J. T. Baker Chemical Co., Phillipsburg,  NJ), while dibu- 
caine was added in saline. In some experiments, as indicated, platelets were 
preincuhated for 30 min at 37"C with 1 nag of leupeptin/ml or for 1-5 rain 
with 10-100 ttg ofcalpeptin/ml (Tsujinaka et al., 1988). Like leupeptin, cal- 
peptin is an inhibitor of sulfhydryl proteases such as calpain.  However, un- 
like leupeptin,  calpeptin readily crosses the plasma membrane and does not 
inhibit the amidolytic activity of thrombin. Leupeptin and calpeptin were 
added to the platelet suspensions in a  final concentration of 0.1-0.2% 
(vol/vol) DMSO. Leupeptin was obtained from Vega Bioehemicals (Tucson, 
AZ), and calpeptin was the generous gift of Dr.  Toshimasa  Tsujinaka of 
Osaka University Medical School, Osaka, Japan. 
Isolation of  Subcellular Fractions 
Platelets were lysed by the addition of an equal volume of buffer containing 
2% (vol/vol) Triton X-100 (Sigma Chemical Co.), 10 mM EGTA, 100 mM 
Tris-HCl, pH 7.4. Triton X-100-insoluble actin filaments and Triton X-100- 
soluble fractions were separated by centrifugation of platelet lysates  at 
100,000 g for 2.5 h. Both cytoplasmic actin filaments and the filaments of 
the membrane skeleton sediment under these conditions (FOx, 1985a). 
Isolation and Analysis of  Platelet Microvesicles 
Platelets were incubated with agents that disrupted the membrane skeleton. 
Intact platelets were then sedimented by centrifugation of the platelet sus- 
pension at 15,600 g for 1 rain at ambient temperatures.  The microvesicles 
were isolated from the 15,600-g supernatant by sedimentation at 100,000 g 
for 2.5 h, or by filtration of the supernatant through polycarbonate filters 
(0.2/~m; Millipore Corp., Bedford,  MA). 
For visualization of microvesicles,  200 ram EGTA (pH 9.0) was added 
to the platelct suspensions to a final concentration of 5 raM. Intact platelets 
were immediately removed by centrifugation, and microvesicles  were iso- 
lated from the resulting superuatant on polycarbonate filters.  The filters 
were fixed with 0.2 M glutaraldehyde,  60 mM cacodylate buffer, pH 7.4. 
Samples were then processed for EM as described previously  (Fox et al., 
1988). 
Analytical Procedures 
Samples  were  analyzed on SDS-polyacrylamide  gels  in the presence of 
reducing agent by the method of Laemmli (1970). Gels were stained with 
Coomassie brilliant blue, and stained proteins quantitated by densitometry. 
The membrane glycoproteins  of 3H-labeled platelets were detected by flu- 
orography of gels treated with EN3HANCE (New England Nuclear,  Bos- 
ton, MA). 
Polyclonal antibodies against actin-binding protein and talin were raised 
in rabbits, affinity purified, and characterized as described previously  (FOx 
et al.,  1985).  Polyclonal  antibodies against GP Ilb-Ma were provided by 
Dr. David Phillips of COR Therapeutics,  Inc. (South San Francisco, CA). 
Normal rabbit  IgG was obtained from Sigma Chemical Co. Immunoblotting 
was performed as described by Towbin et al. (1979). 
Protein concentrations were estimated by the Bio-Rad protein assay (Bio- 
Rad Laboratories, Richmond, CA). Procoagulant activity was assayed as 
described by Bevers ct al. (1982). This assay was not affected by the concen- 
trations of calpeptin that were present. 
Materials and Methods 
Incubation of  Platelet Suspensions 
Venous blood was drawn from healthy adult donors. Platelets were isolated 
by centrifugation and were  radiolabeled as  described previously (Fox, 
1985a).  Surface glycoproteins  were 3H-labeled by the sodium metaperio- 
date/sodium  [3H]borohydride  method,  as  described  previously  (Fox, 
1985a).  Platelets were resnspended at 370C in a Tyrode's buffer containing 
138 mM sodium chloride, 2.9 mM sodium bicarbonate, 0.36 mM sodium 
phosphate, 5.5 mM glucose,  1.8 mM calcium chloride, and 0.49 mM mag- 
nesium chloride, pH 7.4, at a final concentration of 1 x  109 platelets/ml. 
Disruption of the actin-membrane interactions was achieved by incubating 
platelet suspensions at 370C with 0.4-1.0/~M ionophore A23187  (Sigma 
I. Abbreviation  used in this paper: GP, glycoprotein. 
Results 
Loss of  Actin-Membrane Interactions in Platelets in 
which Calpain Was Activated by Dibucaine or 
Ionophore A23187 
The GP Ib-IX complex is the major site of attachment of the 
membrane skeleton to the plasma membrane (Fox, 1985a). 
This complex consists of two disulfide-linked subunits, GP 
Ib~ (Mr  =  145,000)  and GP Ib~ (Mr  =  24,000),  that are 
complexed in a  1:1 ratio with another membrane glycopro- 
rein, GP IX (Mr  =  22,000).  Previously (Fox,  1985b),  we 
have shown that actin-membrane interactions are dissociated 
in platelets in which ealpain is  activated with ionophore 
The Journal of Cell Biology, Volume 111, 1990  484 Figure L SDS-polyacrylamide gels showing calpain-induced hydrolysis of actin-binding protein and decreased association of the GP Ib-IX 
complex with actin filaments in platelets incubated with dibucaine. Suspensions of 3H-labeled platelets were incubated for 5 min in the 
presence or absence of 50 #g of calpeptin/ml. 0.5 mM dibucaine was then added. At the indicated intervals, aliquots were solubilized 
in an SDS-containing buffer and proteins were separated on SDS-polyacrylamide gels containing 7.5 % acrylamide. Hydrolysis of actin- 
binding protein was detected on immtmoblots using actin-binding protein antibodies (A). Additional aliquots were removed from the incuba- 
tion and solubilized in a Triton X-100-eontaining  buffer; the Triton X-100-insoluble actin filaments (B) and Triton X-100-soluble fractions 
(data not shown) were isolated, solubilized in an SDS-containing buffer, and analyzed on SDS-polyacrylamide gels containing a 5-15% 
exponential gradient of acrylamide. ABP, actin-binding protein; 200K, 100K, and 91K are hydrolytic fragments of Mr = 200,000, 100,000, 
and 91,000, respectively, that are generated when actin-binding protein is hydrolyzed within platelets by calpain (Fox et al., 1985). Samples 
containing total platelet suspensions originated from 3 x  10  7 platelets; those containing Triton X-100-insoluble actin filaments originated 
from 6  x  107 platelets. 
A23187,  as  shown by decreased recovery of GP Ib, along 
with the insoluble actin filaments that are sedimented after 
lysis of platelet suspensions with Triton X-100. Another agent 
that activates calpain, in this case without activating the plate- 
lets, is dibucalne (Nachmias et al.,  1979). Fig.  1 shows that 
hydrolysis of actin-binding protein in dibucaine-treated plate- 
lets (Fig.  1 A) was accompanied by dissociation of the GP 
Ib-IX complex from the membrane skeleton, as indicated by 
decreased sedimentation of the three components of the GP 
Ib-IX complex (GP Ib,, GP Ibm, and GP IX) with the Tri- 
ton X-100-insoluble actin filaments (Fig. 1 B) and increased 
recovery of the thre~ glycoproteins in the Triton X-100-sol- 
uble fraction (data not shown). 
In platelets aggregating in response to the physiological 
agonist thrombin, the amount of actin-binding protein that 
is hydrolyzed is small (estimated from immunoblots to be 
less than 10% of the total) (Fox et al., 1983). To determine 
whether hydrolysis of  this smal! amount of  actin-binding pro- 
tein was  sufficient to cause dissociation of the membrane 
skeleton from plasma  membrane glycoproteins, we incu- 
bated platelets with dibuealne under conditions in which the 
extent of hydrolysis of actin-binding protein was comparable 
to that which occurred in aggregating platelets.  Since the 
sensitivity of different platelet suspensions to dibucalne ap- 
peared to vary considerably (in some suspensions actin-bind- 
ing protein was completely hydrolyzed within minutes of ad- 
dition of  0.5 mM dibucaine, whereas other platelets required 
30 min before  hydrolysis was detectable), time-course exper- 
iments were performed. In the experiment shown in Fig.  1, 
for example, incubation of the platelets with dibucaine for 
5 min was sufficient to induce hydrolysis of  amounts of actin- 
binding protein that were comparable to those hydrolyzed in 
Table L Disruption of  Actin-Membrane Interactions  in 
Platelets Exposed to Dibucaine 
GP lb. 
Addition to  Triton X-100-  Triton X-100- 
platelet suspension  insoluble  soluble  Filamentous actin* 
% total platelet GP lb.  % of  total 
None  60.0  +  4.9  40.1  +  1.7  67.8  +  6.1 
Dibucaine  14.7  +  2.7  78.2  +  6.8  58.6  +  3.6 
Suspensions of  platelets that had been surface-labeled by the sodium metaperio- 
date/sodium  [3H]borohydride racthod were incubated for 5 min with no addi- 
tion or with 0.5  mM dibucaine. Values given are the mean  +  SE from three 
donors. 
* Sedimented actin expressed as a percentage of the total platelet actin. 
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ing the effect of leupeptin on the dibu- 
caine-induced hydrolysis of actin-bind- 
ing protein and  release of membrane 
glycoproteins  from the membrane skele- 
ton.  Platelets were surface-labeled by 
the sodium metaperiodate/sodium [3H]- 
borohydride method and suspended at 
1 x  109 platelets/ml in a Tyrode's buf- 
fer. Suspensions were incubated in the 
presence or absence of I mg of leupep- 
tin/ml for 30 min at 37°C. Dibucaine 
was then added to a final  concentration 
of 0.5 mM. (A) At intervals, aliquots of 
platelet suspensions were solubilized in 
an SDS-containing buffer and electro- 
phoresed on SDS-polyacrylamide gels 
containing 7.5% acrylamide,  and  the 
polypeptides were transferred to nitro- 
cellulose paper. Actin-binding protein 
(ABP) and its products of hydrolysis  by 
calpain (200K, 100K, and 91K) were 
detected with antibodies against actin- 
binding protein. (B) Suspensions were 
solubilized directly into  an  SDS-con- 
taining buffer (total platelet suspension) 
or were lysed by addition of a Triton 
X-100-containing buffer. Triton X-100- 
insoluble filaments  were isolated by cen- 
trifugation of  the lysates at 100,000 g for 
2.5 h and solubilized in an SDS-con- 
taining buffer. Samples were electro- 
phoresed through SDS-polyacrylamide 
gels containing a  5-15% exponential 
gradient of acrylamide. 3H-labeled gly- 
coproteins  were detected by  fluorog- 
raphy. 
aggregating cells (i.e., <10% of the total). Quantitation of 
the data presented in Fig. 1 B, shows that hydrolysis of these 
small mounts of actin-binding protein was sufficient to cause 
considerable release of the GP Ib-IX complex from the mem- 
brane skeleton. Thus, using decreased sedimentation of GP 
Iba with,Triton-insoluble actin filaments as a marker for re- 
lease of the complex from the membrane skeleton, 27 % of 
the complex was released after 1 min, and 44 % after 5 min 
of incubation. Using GP IX as a marker, 21% of the complex 
was released after 1 min, and 42 % after 5 min.  The de- 
creased sedimentation of  this glycoprotein complex occurred 
without any significant decrease in the amount of sediment- 
able actih filaments (Table I). Thus, the glycoproteins were 
presumably released from the membrane skeleton because 
the linkage protein, actin-binding protein, was hydrolyzed. 
To confirm that there was a causal relationship between the 
dibucaine-induced hydrolysis of actin-binding protein and 
dissociation of glycoproteins from the membrane skeleton, 
platelets were preincubated with calpain inhibitors. One in- 
hibitor was calpeptin, a recently synthesized inhibitor of  cal- 
pain that readily crosses membranes (Tsujinaka et al., 1988). 
Calpain initially hydrolyzes actin-binding protein into two 
fragments of Mr  =  200,000  and  100,000  and then hydro- 
lyres the M, =  100,000  fragment such that a Mr =  91,000 
polypeptide is generated (Fox et al., 1985). Calpeptin totally 
inhibited both of these actions of calpain (Fig. 1 A). Inhibi- 
tion of the dibucaine-induced hydrolysis of actin-binding 
protein was accompanied by an inhibition of the dibucaine- 
induced release of  the plasma membrane glycoproteins from 
the membrane skeleton (Fig. 1 B). The ionophore A23187- 
induced hydrolysis of a.ctin-binding protein and dissociation 
of the GP Ib-IX complex from the membrane skeleton were 
also totally inhibited by calpepfin (data not shown). The sec- 
ond calpain inhibitor that was used was leupeptin. Although 
leupeptin does not readily cross cell membranes, we found 
that by preincubating the platelets with 1 nag of leupeptin/ml 
for 30 min, sufficient leupeptin entered the platelets to pro- 
duce a partial inhibition of  the subsequent dibucaine-induced 
hydrolysis  of actin-binding protein (Fig. 2 A). A similar level 
of inhibition was reported recently by other workers (Tsu- 
jinaka et al., 1988); these workers also found that preincuba- 
tion of  the platelets with high concentrations of leupeptin was 
needed to effect entry of the inhibitor into platelets. Leupep- 
tin also caused partial inhibition of disruption of acfin-mem- 
brane interactions (Fig. 2 B, compare fourth lane with third 
lane). 
Disruption of  the Actin-Membrane Interactions Is 
Accompanied by Shedding of  Microvesicles  from the 
Plasma Membrane 
By analogy to the red blood cell (Lux, 1979;  Mohandas et 
The Journal  of Cell Biology,  Volume 111, 1990  486 Figure 3.  Electron micrographs of microvesicles that were released during incubation of platelet suspensions with agents that disrupted 
actin-membrane interactions. Platelet suspensions were incubated alone (A) or in the presence of 0.4/xM ionophore A23187 for 5 min 
(B) or 0.5 mM dibucaine for 5  min (C). Intact platelets were sedimented by centrifugation of the suspensions at 15,600 g  for 1 min. 
Microvesicles were isolated from the resulting supernatant by filtering the supernatant through polycarbonate filters that had a 0.2-/zm 
pore size. The polycarbonate,  filters were fixed and then examined by EM. Microvesicles were present in suspensions of platelets in which 
the actin-membrane interactions had been disrupted. These vesicles ranged in size from '~800 nm in diameter to vesicles that were small 
enough to enter the pores of the filters. Many of the vesicles were empty, whereas others contained an amorphous material. Bar,  1 #m. 
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gels  showing the  surface  glyco- 
protein composition of the micro- 
vesicles  shed  from  the  plasma 
membrane  during  exposure  of 
platelets to agents that disrupted 
the membrane skeleton. Platelets 
in which  the  surface membrane 
glycoproteins had been 3H-labeled 
were solubilized directly with an 
SDS-containing buffer (lane 1) or 
were incubated with 0.5 mM di- 
bucaine  for  10 rain  (lane  2)  or 
1 #M ionophore  A23187 for l0 
rain  (lane 3).  Suspensions  were 
centrifuged at 15,600 g for 1 rain 
to sediment intact platelets.  The 
material remaining in the superna- 
tant was centrifuged at 100,000 g 
for 2.5 h to obtain the microves- 
icles.  Microvesicles  were  elec- 
trophoresed  through  SDS-gels 
containing  a 5-15%  exponential 
gradient  of  acrylamide.  3H-la- 
beled  membrane  glycoproteins 
were  detected  by  fluorography. 
Lane 1 contained 3  ×  107 plate- 
lets from a total platelet suspension; lane 2 contained the microvesi- 
cles isolated from 24  ×  107 of the platelets shown in lane 1. Lane 
3 contained microvesicles isolated from 6 ×  107 platelets in a sep- 
arate experiment. 
intact platelets were 3H-labeled by the  sodium metaperio- 
date/sodium  [3H]borohydride technique and platelets were 
incubated with agents that decreased association of the mem- 
brane skeleton with the plasma membrane. At the end of the 
incubation, intact platelets were removed by low-speed cen- 
trifugation.  The microvesicles were isolated by high-speed 
centrifugation  of the  platelet-free  supernatant.  Glycopro- 
teins present on the microvesicles (Fig. 4) were identified (on 
two-dimensional  nonreduced-reduced  SDS  gels  [data  not 
shown])  as GP Ia, the three components of the GP Ib-IX 
complex, GP llb-l/Ia and GP IV. At least one glycoprotein 
(GP V) was absent. Based on these observations, we chose 
to assay the amount of microvesicles by the amount of GP 
Ib=, GP I/Ia, GP Iba, or GP IX shed from the platelet. 
As an initial test of the idea that microvesicles were shed 
because actin-membrane interactions  were disrupted,  the 
time courses of actin-binding protein hydrolysis, release of 
the GP Ib-IX complex from the membrane skeleton, and the 
shedding of microvesicles were compared. As shown in Fig. 
5, the time courses of the three events were quite similar. In- 
terestingly, the shedding of microvesicles appeared to lag be- 
hind the hydrolysis of actin-binding protein and release of 
GP  Ib-IX  from  the  membrane  skeleton.  Only  a  small 
amount of GP Ib-IX was present in the microvesicles com- 
pared with the amount that was released from the membrane 
skeleton.  These results are consistent with the hypothesis 
that several actin-membrane interactions must be disrupted 
before a  region of membrane is destabilized sufficiently to 
bleb off. 
al.,  1983),  we predicted that the membrane skeleton might 
contribute to maintaining the stability of the plasma mem- 
brane;  thus,  one  consequence  of disruption  of the  actin- 
membrane interactions might be the shedding of microvesi- 
des  from the  plasma membrane.  To test this  hypothesis, 
platelets were incubated with the agents that decreased the 
association of the membrane skeleton with the plasma mem- 
brane. Incubations were terminated by sedimentation of in- 
tact platelets at 15,600 g. The resulting platelet-free superna- 
tant was passed through filters, and the filters (Fig. 3, A-C) 
were examined morphologically to determine whether any 
microvesicles were present. Few microvesicles were recov- 
ered from suspensions of control platelets (Fig. 3 A). How- 
ever, microvesicles were present in suspensions of platelets 
in which the membrane skeleton had been disrupted by ei- 
ther ionophore A23187 (Fig. 3 B) or dibucaine (Fig. 3 C). 
The vesicles varied considerably in size, from ~800 nm in 
diameter to vesicles as small as 40 nm that were visualized 
in the 200-nm pores of the filters. Many of the vesicles ap- 
peared empty. Others contained an amorphous material whose 
appearance resembled the membrane skeleton that we have 
described previously (Fox et al., 1988). Presumably, the ves- 
icles were shed from regions of the plasma membrane that 
had lost their association with the membrane skeleton; the 
vesicles that contained amorphous material may have formed 
by fusion of two separate regions that had lost actin-mem- 
brane interactions and by their detachment along with the in- 
tervening region of membrane, which remained associated 
with pieces of the submembranous skeleton. 
To be able to quantitate  the formation of microvesicles, 
plasma membrane glycoproteins present on the microvesi- 
cles were identified. The surface-membrane glycoproteins of 
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Figure 5.  Time course  of dibucaine-induced  hydrolysis of actin- 
binding protein,  release of the GP Ib-IX complex from the mem- 
brane skeleton, and the shedding of microvesicles from the plasma 
membrane. Platelets in which the surface-membrane glycoproteins 
had been 3H-labeled were incubated with 0.5 mM dibucaine  for 
0-15 min. The extent of hydrolysis of actin-binding protein (ABP) 
was assessed by quantitation  of the amount  of the Mr  =  91,000 
hydrolytic fragment by densitometry  of immunoblots. The release 
of  the GP Ib-IX  complex from the membrane skeleton was assessed 
by the amount of GP Ibo and GP IX that were soluble in Triton 
X-100, as  quantitated  by densitometry  of autoradiograms.  The 
shedding of  microvesicles from the plasma membrane was assessed 
by the release of GP Ib~ and GP IX from the platelet surface, as 
quantitated by densitometry of autoradiograms.  (o), Triton X-100- 
soluble  GP Ib~ plus  GP IX;  (o)  91-kD hydrolytic  fragment  of 
actin-binding protein; (A) GP Ib~ plus GP IX in the microvesicles. 
The Journal of Cell Biology, Volume 111, 1990  488 Figure 6. Effect of leupeptin on the dibucaine-induced hydrolysis of actin-binding protein and shedding of microvesicles from the plasma 
membrane. Suspensions of unlabeled platelets were incubated for 30 min in the presence or absence of 1 mg of leupeptin/ml. Dibucaine 
was then added to a final concentration of  0.5 mM. (A) At intervals, aliquots of platelet suspensions were solubilized in an SDS-containing 
buffer and electrophoresed on SDS-polyacrylamide  gels containing 7.5 % acrylamide. The polypeptides were detected with Coomassie bril- 
liant blue. (B) At intervals, intact platelets were removed from suspension  by centrifugation  at 15,600 g for 1 min. The resulting platelet-free 
supernatant was dotted onto nitrocellulose paper, which was incubated with antibodies against the GP IIb-IIIa complex and then with 125I- 
labeled protein A. The amount of GP IIb-IIIa was quantitated by densitometry of autoradiograms and expressed as a percentage of the 
total amount of GP Ilb-IIIa in the platelet suspension. 
As a further test of the idea that microvesicles were shed 
as a consequence of dissociation of the membrane skeleton 
from the  plasma  membrane,  platelets  were  preincubated 
with inhibitors of calpain prior to the addition of dibucaine 
or ionophore A23187.  These inhibitors decreased the shed- 
ding of microvesicles from the plasma membrane.  Thus, 
leupeptin, which partially inhibited dibucaine-induced hy- 
drolysis of actin-binding protein  (Fig.  6  A),  partially in- 
hibited the shedding of microvesicles (Fig. 6 B). Calpeptin, 
which totally inhibited the disruption of actin-membrane in- 
teractions (Fig. 1 B) almost totally inhibited the dibucaine- 
induced (Fig. 7 A) and the ionophore A23187-induced (Fig. 
7 B) shedding of microvesicles from the plasma membrane. 
Characterization  of the Composition and Functional 
Activity of the Microvesicles 
The protein composition of the microvesicles was examined 
on SDS-polyacrylamide gels.  Ionophore A23187  induced 
secretion of the contents of the a-granules; thus, several of 
the major proteins present in the low-speed supernatant from 
ionophore-treated platelets were s-granule proteins throm- 
bospondin, fibrinogen,/~-thromboglobulin, and platelet fac- 
tor 4 (Fig. 8 A, lane 2). Some of these proteins remained in 
the supernatant (Fig. 8 A, lane 3) when microvesicles were 
sedimented by high-speed centrifugation, but considerable 
(although variable) amounts of the secreted proteins sedi- 
mented at high g forces with the microvesicles (Fig. 8 A, lane 
4). Several other proteins also sedimented. One of these was 
identified as actin (by two-dimensional isoelectric focusing 
[data not shown]); others were identified by immunoblotting 
as the Mr =  200,000 fragments generated when actin-bind- 
ing protein (Fig.  8 B) and talin (Fig.  8 C) are hydrolyzed 
by calpaln. In many experiments variable amounts of the in- 
tact proteins were also present. The invariable presence of 
hydrolytic fragments is consistent with the microvesicles be- 
ing shed from regions of the platelet in which calpain was 
active. The composition of the particulate material shed from 
dibucalne-treated platelets was quite  similar to  that from 
ionophore A23187-treated platelets except that the ~t-granule 
proteins were not present (data not shown). Another differ- 
ence was that considerable amounts of myosin were present, 
perhaps because in dibucalne-treated platelets (in which se- 
cretion does not occur) myosin remained near the membrane, 
while in ionophore A23187-treated platelets it became cen- 
tralized. 
Microvesicles Shed  from Platelets Contain 
Procoagulant Activity 
Both of the agents that dissociated the membrane skeleton 
from its membrane attachment site (dibucaine (Fig: 9 A) and 
ionophore A23187 [data not shown]) induced the generation 
of  procoagulant activity in suspensions of  platelets. Procoag- 
ulant activity was present in the platelet-free supernatant (Fig. 
9 A).  This platelet-free activity appeared to be associated 
with the microvesicles: it was enriched in the microvesicles 
that were sedimented from the platelet-free supernatant (Ta- 
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effect of calpeptin on the shedding of microvesicles. Suspensions 
of 3H-labeled platelets were preincubated for 5 min in the pres- 
ence of calpeptin: 0 #g/ml (lanes 1), 10 #g/ml (lanes 2), 50 #g/ml 
(lane 3), or 100 #g/ml (lane 4). Suspensions were then incubated 
with 0.5 mM dibucaine for 5 min (A) or with 1 #M ionophore 
A23187 for 5 min (B). Incubations were terminated by removal  of 
intact platelets. Microvesicles that had been shed from 6  x  l0  s 
platelets were isolated from the resulting supernatant by centrifuga- 
tion.  Samples were solubilized in an SDS-containing buffer and 
electrophoresed through SDS-polyacrylamide gels containing a 
5-15% exponential gradient of acrylamide. 3H-labeled glycopro- 
teins were detected by tluorography. 
ble II),  and it was nearly absent in the supernatant from 
platelets in which disruption of actin-membrane interactions 
and shedding of microvesicles had been prevented by inclu- 
sion of calpeptin (Fig. 9 B). 
Discussion 
Previously, we have suggested that platelets contain a mem- 
brane skeleton that is distinct from the cytoplasmic compo- 
nent of the cytoskeleton and lines the plasma membrane in 
much the same way as the skeleton of the red blood cell lines 
its membrane (Fox et al.,  1988; Fox and Boyles, 1988).  To 
determine whether the platelet membrane skeleton, like that 
of  the red blood cell, stabilizes the plasma membrane, plate- 
lets were incubated with ionophore A23187 and dibucaine, 
agents that activated calpain i~nd  thus disrupted the associa- 
tion between the membrane skeleton and plasma membrane 
glycoproteins.  Incubation  of  platelets  with  these  agents 
caused the shedding of  procoagulant-rich microvesicles from 
the plasma membrane. These microvesicles contained cal- 
pain-generated hydrolytic fragments of actin-binding protein 
and talin. Shedding of the microvesicles correlated with the 
extent of disruption of the membrane skeleton. When dis- 
ruption of  the membrane skeleton was inhibited by inhibitors 
of calpain, the shedding of the microvesicles was inhibited. 
These results are consistent with the hypothesis that micro- 
vesicles form as a consequence of the calpain-induced dis- 
ruption of actin-membrane interactions. We suggest, there- 
fore,  (a)  that association of the membrane skeleton with 
membrane glycoproteins stabilizes the plasma membrane of 
unstimulated platelets, preventing the shedding of procoagu- 
lant-rich microvesicles from the plasma membrane, and (b) 
that one consequence of the activation of calpain in platelets 
can be the shedding of procoagulant-rich microvesicles. 
The reason that the microvesicles contain procoagulant ac- 
tivity is not clear. Zwaal and co-workers have noted a corre- 
lation between the extent of hydrolysis of actin-binding pro- 
tein within the platelet and the externalization of negatively 
charged phospholipids (Comfurius et ai., 1985).  They sug- 
gested that  the platelet cytoskeleton was  responsible  for 
maintaining the asymmetry of the phospholipids, and that 
hydrolysis of the cytoskeleton during platelet activation al- 
lowed negatively charged phospholipids to "flip" to the outer 
bilayer, where they could provide new binding sites for the 
prothrombinase complex. Although we have not determined 
whether expression of the procoagulant activity detected in 
the present study results from externalization of phospholip- 
ids, our data are consistent with the idea that procoagulant 
activity can be generated when actin-membrane interactions 
are disrupted. Thus, the agents that disrupted the membrane 
skeleton also led to increased procoagulant activity, some of 
which was shed with the microvesicles. One possible expla- 
nation for the presence of procoagulant activity in microvesi- 
cles could therefore be that dissociation of the membrane 
skeleton from the plasma membrane results in increased ex- 
pression of binding sites for the prothrombinase complex on 
regions of the membrane that are subsequently shed. How- 
ever, other possibilities exist; for example, procoagulant ac- 
tivity may occur as a consequence of negatively charged lipid 
becoming exposed during the physical process of microvesi- 
cle formation. Further studies will be needed to evaluate 
these possibilities. 
The present studies provide evidence that microvesicles 
are shed when calpain is active in platelets and are consistent 
with the hypothesis that this results from the calpain-me- 
diated disruption of the membrane skeleton. Calpain is acti- 
vated when platelets aggregate in response to a physiological 
agonist. Although the agonist-induced activation of calpain 
was first reported in 1983 (Fox et al.,  1983),  the possibility 
that calpain plays a  role in stimulus-response coupling in 
platelets has not been widely accepted. The main reason for 
this may be that only small amounts of substrates are hydro- 
lyzed (typically, <10%  of the total actin-binding protein in 
platelets is hydrolyzed). The present study shows that hydro- 
lysis of these small amounts of substrate is sufficient to cause 
release of 40-50% of the GP Ib-IX complex from the mem- 
brane skeleton and to elicit the generation of procoagulant- 
rich microvesicles. Recently, Ezzell et al. (1988) estimated 
that only •20%  of the total actin-binding protein in platelets 
is associated with the GP Ib-IX complex. Thus, for hydroly- 
sis of <10%  of the total actin-binding protein to result in 
release of 40-50% of the GP Ib-IX complex from the mem- 
brane skeleton, one would have to propose that the mem- 
The Journal of Cell Biology, Volume  111, 1990  490 Figure 8. SDS-polyacrylamide gels showing the protein composition of the microvesicles shed from the plasma membrane during exposure 
of platelets to agents that disrupted the membrane skeleton. Platelet suspensions were stirred in the presence of 1 ttM ionophore A23187 
for 10 min. Control suspensions (lanes 1 ) or suspensions that had been stirred in the presence of ionophore (lanes 2) were solubilized 
directly into an SDS-containing buffer or were centrifuged at 15,600. g for 1 rain to sediment intact platelets. The material remaining in 
the supernatant from ionophore-treated platelets was either solubilized in SDS (lanes 3) or centrifuged at 100,000 g for 2.5 h to obtain 
the 100,000-g supernatant (lanes 4) and the sedimented microvesicles (lanes 5). All samples were electrophoresed through SDS-gels con- 
taining a 5-15% exponential gradient of acrylamide. Lanes 1 and 2 contained protein from 3  ×  107 platelets; the remaining lanes con- 
talned protein originating from 6  ×  107 platelets. In A, proteins were detected with Coomassie brilliant blue. In B and C, actin-binding 
protein and talin were detected on immunoblots. ABP, actin-binding protein; TSP, thrombospondin; BIG, #-thromboglobulin; PF4, platelet 
factor 4. The Mr =  200,000 products of hydrolysis of actin-binding protein and talin are both shown as 200K. 
brane-bound pool of actin-binding protein was preferentially 
hydrolyzed by calpain. This possibility is not unreasonable, 
given the considerable body of literature suggesting that cal- 
pain can be activated by binding to the plasma membrane 
(for review, see Suzuki et al. [1988]). There are many reports 
that procoagulant-rich microvesicles are shed from platelets 
in a variety of  physiological and pathological conditions (Bode 
et al., 1985; Crawford, 1971; Dombrose et al., 1981; George 
et al.,  1982; 1986a,b; Sandberg et al.,  1982; 1985; Sims et 
al., 1989; Solberg et al., 1987; Wiedmer et al., 1986; Wolf, 
1967).  The present study raises  the possibility that these 
vesicles may form as a consequence of the calpain-induced 
disruption of actin-membrane interactions. Studies are un- 
der way to test this hypothesis. 
The only cell type in which a membrane skeleton has been 
well characterized is the red blood cell. In this cell, the mem- 
brane skeleton also stabilizes the plasma membrane. The ex- 
istence of a variety of hereditary defects has provided clear 
evidence that defective association of the skeleton with the 
plasma  membrane leads  to the shedding  of microvesicles 
from the plasma membrane (Lux, 1979). As in the platelet, 
there is also evidence that the membrane skeleton prevents 
the expression of proeoagulant activity on the surface of the 
red blood cell by maintaining the asymmetry of negatively 
charged phospholipids (Franck et al.,  1985). The red blood 
cell membrane skeleton consists of a network of short actin 
filaments, cross-linked by spectrin. It is so closely adherent 
to the plasma membrane that it is hard to visualize in the 
presence of  an intact plasma membrane (Hainfeld and Steck, 
1977; Liu et al., 1987; Shen et al., 1986). However, because 
the red blood cell does not contain cytoplasmic actin fila- 
ments, the membrane skeleton is the only structure that re- 
mains after solubilization of the membranes with detergent. 
Thus, the red blood cell membrane skeleton has been readily 
amenable to study and has been shown to regulate many of 
the properties of the plasma membrane. 
In other cell types, the major structure remaining after 
solubilization of the plasma membrane with detergents is a 
dense network of cytoplasmic actin filaments. Thus, that a 
membrane skeleton may also exist in other cell typeg has of- 
ten been overlooked. Recently, however, the observation that 
proteins such as spectrin, 4.1, or ankyrin are present in a 
sub-membranous location has been taken as an indication 
that a membrane skeleton may be present in other ceils (Ben- 
nett,  1985;  Marchesi,  1985).  Further,  the  finding  that  a 
detergent-insoluble  shell  containing  uncharacterized  pro- 
teins remains after extraction of  various cell types under con- 
ditions in which cytoplasmic actin filaments have been de- 
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Figure 9. Generation of  procoagulant activity on dibucaine-treated platelets. (,4)  Platelet suspensions were incubated with 0.5 mM dibucaine. 
At intervals, aliquots of suspension were removed and the procoagulant activity in the total suspension (solid line) or in the supernatant 
remaining after the intact platelets had been removed by sedimentation (broken line) was assayed. The numbers in parentheses show the 
prothrombinase activity in the supernatant expressed as a percentage of that in the total platelet suspension. (B) Platelets were preincuhated 
in the presence (e) or absence (o) of 50 #g of calpeptin/ml for 5 rain before dibucaine addition. The procoagulant activity present in 
the platelet-free supernatant was assayed at the intervals indicated. 
po!ymerized (Ben-Ze'ev et al.,  1979;  Apgar et al.,  1985; 
1986) has led to the suggestion that a peripheral layer of pro- 
teins may function as a  membrane skeleton in cells other 
than the erythrocyte. Thus, the findings on the role of the 
membrane skeleton in platelets may have relevance to other 
cell types. Microvesicles that are shed physiologically, for 
example, as a mechanism of modifying the cell surface dur- 
ing development (Johnstone et al.,  1987), or of enhancing 
cell-substrate attachment (Schubert et al., 1983), or the pro- 
coagulant-rich microvesicles that are shed from tumor cells 
(Van De Water et al., 1985) could result from modulation of 
components of a membrane skeleton. The present evidence 
that calpain-induced changes to the membrane skeleton can 
regulate the stability of the plasma membrane therefore sug- 
gests a general mechanism by which membrane-associated 
properties of cells might be regulated. 
Table II. Enrichment of  Dibucaine-induced 
Procoagulant Activity in the Platelet Microvesicles  That 
Fragmented  from the Plasma Membrane 
Specific procoagulant activity 
Fraction  (x  10  ~°) 
tool of thrombin/min/mg of protein 
Low-speed  25.7 
supernatant 
High-  speed  19.3 
supernatant 
High-speed  111.8 
pellet 
(microvesicles) 
Platelet suspensions  were incubated for 15 rain in the presence of 0.5 mM dibu- 
caine.  Intact platelets were removed by centrifugation of the suspension at 
15,600 g for 1 min. The resulting supernatant was centrifuged at 100,000 g for 
2.5 h to sediment the microvesicles. 
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